The Marine-Derived Sipholenol A-4-O-3′,4′-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling

Mohamed A. Akl(University of Louisiana at Monroe), Khalid A. El Sayed(University of Louisiana at Monroe)

Marine Drugs

April 14, 2014

10.3390/md12042282

Cited by 26

Related Papers

Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling

|Marine Drugs|2015|38

Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling

|International Journal of Molecular Sciences|2018|36

(−)-Oleocanthal Prevents Breast Cancer Locoregional Recurrence After Primary Tumor Surgical Excision and Neoadjuvant Targeted Therapy in Orthotopic Nude Mouse Models

|Cancers|2019|34

(−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo

|Nutrients|2019|31

The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor

|Oncotarget|2016|21